DRI Healthcare Trust (TSE:DHT.UN) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of DRI Healthcare Trust (TSE:DHT.UN) have been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is C$18.25.

A number of brokerages have commented on DHT.UN. Truist Financial lowered their target price on DRI Healthcare Trust from C$17.00 to C$14.00 in a report on Thursday, July 25th. Scotiabank lifted their price objective on DRI Healthcare Trust from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th.

DRI Healthcare Trust Trading Up 36.6 %

DHT.UN opened at C$13.17 on Friday. DRI Healthcare Trust has a one year low of C$10.39 and a one year high of C$17.43. The business’s fifty day moving average is C$13.18 and its two-hundred day moving average is C$13.70.

DRI Healthcare Trust Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 18th. Shareholders of record on Friday, October 18th were given a $0.085 dividend. This represents a $0.34 annualized dividend and a yield of 2.58%. The ex-dividend date of this dividend was Friday, September 27th. DRI Healthcare Trust’s dividend payout ratio (DPR) is presently -920.00%.

DRI Healthcare Trust Company Profile

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.